If our assumption mentioned above is correct, then these data suggest that t(4;11) translocation in these probands may be generated later during fetal development, most probably in irrelevant cells, thus not representing a higher risk for their carriers to develop an aggressive MLL-AF4+ B-ALL at or shortly after birth. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.